Kazuo Oshimi

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim et al. · Journal of Clinical Oncology · 2011 · 602 citations

Pharmacy, Oncology, Pharmacotherapy +13

Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan

Eiichi Ishii, Shouichi Ohga, Shinsaku Imashuku et al. · International Journal of Hematology · 2007 · 464 citations

Medicine, Hematology, Pathology +12

The Lymphoproliferative Disease of Granular Lymphocytes: Updated Criteria for Diagnosis

Gianpietro Semenzato, Renato Zambello, Gordon Starkebaum et al. · Blood · 1997 · 348 citations

Medicine, Hematology, Pathology +12

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi et al. · Journal of Clinical Oncology · 2009 · 338 citations

Medicine, Oncology, Radiation Oncology +14

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

Ritsuro Suzuki, Junji Suzumiya, Motoko Yamaguchi et al. · Annals of Oncology · 2009 · 260 citations

Life Sciences, Immunology, Oncology +12